RECRUITING

Drinking, Acetate, and Stress

Description

The purpose of this study is to learn how drinking alcohol affects how people experience stress and how that is affected by the body's chemistry. Specifically, the investigators will be studying relationships of drinking and a stress hormone called cortisol. The investigators believe that results will lead us to find more effective ways to help people stop or reduce drinking when participants are drinking at harmful levels.

Study Overview

Study Details

Study overview

The purpose of this study is to learn how drinking alcohol affects how people experience stress and how that is affected by the body's chemistry. Specifically, the investigators will be studying relationships of drinking and a stress hormone called cortisol. The investigators believe that results will lead us to find more effective ways to help people stop or reduce drinking when participants are drinking at harmful levels.

Role of Acetate in Heavy Drinking

Drinking, Acetate, and Stress

Condition
Alcohol Use Disorder
Intervention / Treatment

-

Contacts and Locations

New Haven

The Anlyan Center, 300 Cedar St., New Haven, Connecticut, United States, 06519

New Haven

Yale University, New Haven, Connecticut, United States, 06520

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Provision of signed and dated informed consent form
  • * Stated willingness to comply with all study procedures and availability for the duration of the study
  • * Medically stable male or female, aged 18-55.
  • * Able to read, write and complete a multitude of self-assessments in English
  • * Meets DSM-5 criteria for current Alcohol Use Disorder (AUD)
  • * Participants who have Alcohol Use Disorder and are actively drinking must be willing to receive (at no cost) inpatient treatment for AUD for a period of up to 30 days. Participants who have been treated for an Alcohol Use Disorder and are now sober three months or longer will NOT be required to go inpatient.
  • * Subjects with any significant current medical conditions (neurological, cardiovascular, endocrine, thyroid, renal, liver), seizures, delirium or hallucinations, or other unstable medical conditions, including HIV.
  • * Current DSM-5 substance use disorder (other than AUD or tobacco use disorder)
  • * Any metallic objects implanted in their body which would make imaging unsafe (pacemaker, etc)
  • * Claustrophobia, or other inability to participate in an MRI
  • * A positive test result at intake appointment and subsequent appointments on urine drug screens conducted for illicit drugs. (Note: participants will not be paid for study visits if they test positive for an illicit drug and will be immediately excluded from study).
  • * Women who are pregnant or nursing. Women who have an IUD that would make imaging unsafe.
  • * Recent taking of medications that may influence study outcomes (e.g., disulfiram, naltrexone, acamprosate, anticonvulsants).
  • * Subjects likely to exhibit clinically significant alcohol withdrawal during the study.

Ages Eligible for Study

18 Years to 50 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Yale University,

Graeme Mason, Ph.D., PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

2030-01